Xin Yin

1.7k citations
76 papers · 1.1k indexed · h-index 19
    • Cancer-related molecular mechanisms research 9
  • Oncology top 10%
    • Inflammatory Biomarkers in Disease Prognosis 12
    • Cancer Immunotherapy and Biomarkers 11
    • Gastric Cancer Management and Outcomes 23
    • Metastasis and carcinoma case studies 9
    • Ferroptosis and cancer prognosis 6
    • RNA modifications and cancer 14
    • Epigenetics and DNA Methylation 8

Xin Yin

74 papers receiving 1.1k citations

Peers

Xin Yin
Comparison fields: 5 of 106
  • Cancer Research 386
  • Oncology 355
  • Pulmonary and Respiratory Medicine 294
  • Molecular Biology 585
  • Immunology 130
Replace Liangliang Wu with:
Liangliang Wu China
Qing Chen China
Shingo Inaguma Japan
Jingjing Zhao China
Jonathan M. Harnoss Germany
Guanglong Dong China
Carmen Z. Michaylira United States
Étienne Buscail France
Kyu Yeoun Won South Korea
Stefan David United States
Xin Yin relative to Liangliang Wu China Liangliang Wu's profile →
Citations per field
00.5×1.5×1.9×
Liangliang Wu · 1×
Citations per year

Countries citing papers authored by Xin Yin

Since Specialization
Citations

This map shows the geographic impact of Xin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Yin more than expected).

Fields of papers citing papers by Xin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Yin. The network helps show where Xin Yin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xin Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xin Yin Line = papers co-authored together Xin Yin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 202411
4 20231
5 202317
6 20239
7 20235
8 20235
9 202245
10 20222
11 202213
12 20223
13 202111
14 202146
15 202121
16 202117
17 202036
18 2020116
19 20191
20 201977

About Xin Yin

Xin Yin is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 76 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (23 papers), RNA modifications and cancer (14 papers), Inflammatory Biomarkers in Disease Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer-related molecular mechanisms research (9 papers), Metastasis and carcinoma case studies (9 papers), Epigenetics and DNA Methylation (8 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Cancer Research (386 citations), Oncology (355 citations) and Pulmonary and Respiratory Medicine (294 citations). Xin Yin has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yingwei Xue, Tianyi Fang, Yimin Wang, Yufei Wang, Shenghan Lou, Miao Li, Tianshu Yang, Mingjun Gu, Xiangqi Li and Lianyong Liu.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026